Intel Corporation
Advised Intel Corporation on its $375 million acquisition from InterDigital of roughly 1,700 patents and patent applications primarily related to wireless communication technologies (2012).
Threshold Pharmaceuticals
Advised Threshold Pharmaceuticals in its agreement with Merck KGaA for the development and commercialization of Threshold’s cancer candidate, TH-302, with Threshold receiving up to $550 million in upfront fees and potential development and commercialization milestone payments as well as royalties (2012).
Intel Corporation
Advised Intel Corporation on IP issues in connection with its $1.4 billion purchase of Infineon Technologies AG’s Wireless Solutions business (2010-2011).
On Semiconductor Corporation
Advised On Semiconductor Corporation on IP issues in connection with its $31 million acquisition of Cypress Semiconductor Corporation’s image sensor business unit (2010-2011).
Advanced Micro Fabrication Equipment, Inc.
Advised Advanced Micro Fabrication Equipment, Inc. (AMEC), on IP issues in connection with settlement of certain disputes with Applied Materials, Inc. (2010).
EW Scripps and United Media
Advised EW Scripps and United Media on IP issues in connection with their sale of rights in Charles Schulz’s “Peanuts” comic strips and characters to Iconix Brand Group and Schulz’s heirs (2010).
Major consumer products company
Advised a major consumer products company on copyright and other IP issues in connection with an online music talent competition (2010).
Otto Group
Advised Germany’s Otto Group in its acquisition of the “Bombay” trademarks and related assets from Hilco Consumer Capital and Gordon Brothers Group (2010).
Astellas Pharmaceuticals, Inc.
Advised Astellas Pharmaceuticals, Inc., on license agreement with Ironwood Pharmaceuticals regarding the exclusive development and commercialization by Astellas of Ironwood’s linaclotide compound in Asia (2009).
Gruppo Campari
Advised Gruppo Campari on IP issues in connection with its $575M purchase of the Wild Turkey brand and related assets from Pernod Ricard (2009).
Freescale Semiconductor, Inc.
Advised Freescale Semiconductor, Inc., on IP issues in connection with the sale of its Imaging Systems Group to Conexant Systems, Inc. (2008).
Leading supplier of mobile handsets
Advised a leading supplier of mobile handsets on license and collaboration agreements with major semiconductor companies regarding the design and supply of 3G chipsets (2007–2008).
Freescale Semiconductor, Inc.
Advised Freescale Semiconductor, Inc., on IP issues in connection with the sale of its Gallium Arsenide (GaAs) power amplifier business to Skyworks Solutions, Inc. (2007).
Intercell AG
Advised Intercell AG on marketing and distribution agreement with Novartis for Intercell’s Japanese Encephalitis vaccine in Europe, the U.S., and certain other markets (2006).
Intercell AG
Advised Intercell AG in its strategic alliance with Biological E Ltd. for development, manufacture, and commercialization of Japanese Encephalitis vaccine in Asia (2005).
Intercell AG
Advised Intercell AG on several agreements with Merck & Co., Inc., regarding the development and commercialization of a vaccine against Group A Streptococcus and Staphylococcus aureus infections (2004–2006).
Fujitsu Limited
Advised Fujitsu Limited on IP and commercial law issues in its collaboration with Sun Microsystems, Inc. (now Oracle), regarding the development and commercialization of server products (2004).